Русский
Current aspects of the treatment of urogenital atrophy (based on the consensus of britain society of menopause)
DOI: https://dx.doi.org/10.18565/urology.2019.5.150-154
V.E. Balan, E.V. Tikhomirova, A.V. Tsarkova, Z.K. Gadzhieva
1) GBUZ MO Moscow Regional Scientific and Research Institute of Obstetrics and Gynecology (director – MD, professor Petrukhin V.A.), Moscow, Russia; 2) FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia, Moscow, Russia
The symptoms of genitourinary syndrome of menopause are considered as typical for late menopausal period. However, these symptoms are increasingly diagnosed in perimenopausal and early menopausal period. Women seldom seek medical care, since autonomic menopausal symptoms are usually more bothersome. In many cases, doctors are not sure in necessity of any hormonal replacement. Moreover, a confusion still exists between systemic hormone replacement therapy (HRT) and local estrogen preparations. Besides moisturizers and local intravaginal estrogens, novel treatment modalities have emerged that extend therapeutic armamentarium.
Keywords: non-hormonal moisturizers, vaginal estrogens, urine incontinence, pseudocystitis, non- sexual dysfunction, pruritus, genitourinary syndrome of menopause (GSM) dryness, dyspareunia
About the Autors
Corresponding author: E.V. Tikhomirova – Ph.D., senior researcher at the Outpatient Department of GBUZ MO Moscow Regional Scientific and Research Institute of Obstetrics and Gynecology, Moscow, Russia; e-mail: heltik03@gmail.com
